By Ed Susman, Contributing Writer, MedPage Today
Published: April 12, 2010
Reviewed by Ari Green, MD; Assistant Professor, University of California, San Francisco and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner
Published: April 12, 2010
Reviewed by Ari Green, MD; Assistant Professor, University of California, San Francisco and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner
TORONTO -- Invasive procedures designed to correct venous blood flow in multiple sclerosis patients should not be performed until clinical trials can prove that the treatment is safe and effective, physicians here suggested.
John Corboy, MD, professor of neurology at the University of Colorado School of Medicine, Denver, reviewed studies performed by Paolo Zamboni, MD, professor of vascular surgery at the University of Ferrara in Italy. Zamboni has been the leading investigator into the possibility that chronic venous insufficiency could be a causative problem in multiple sclerosis.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
0 comments:
Post a Comment